首页> 美国卫生研究院文献>Scientific Reports >A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity
【2h】

A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity

机译:一种新颖的网络正则化矩阵分解方法用于检测具有患者间异质性的肿瘤样本中的突变癌症基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Inter-patient heterogeneity is a major challenge for mutated cancer genes detection which is crucial to advance cancer diagnostics and therapeutics. To detect mutated cancer genes in heterogeneous tumour samples, a prominent strategy is to determine whether the genes are recurrently mutated in their interaction network context. However, recent studies show that some cancer genes in different perturbed pathways are mutated in different subsets of samples. Subsequently, these genes may not display significant mutational recurrence and thus remain undiscovered even in consideration of network information. We develop a novel method called mCGfinder to efficiently detect mutated cancer genes in tumour samples with inter-patient heterogeneity. Based on matrix decomposition framework incorporated with gene interaction network information, mCGfinder can successfully measure the significance of mutational recurrence of genes in a subset of samples. When applying mCGfinder on TCGA somatic mutation datasets of five types of cancers, we find that the genes detected by mCGfinder are significantly enriched for known cancer genes, and yield substantially smaller p-values than other existing methods. All the results demonstrate that mCGfinder is an efficient method in detecting mutated cancer genes.
机译:患者间的异质性是突变癌症基因检测的主要挑战,这对于提高癌症诊断和治疗水平至关重要。为了检测异质性肿瘤样品中的突变癌症基因,一种突出的策略是确定基因在其相互作用网络环境中是否经常突变。但是,最近的研究表明,处于不同干扰路径的某些癌症基因在不同的样本子集中发生了突变。随后,这些基因可能不会显示出明显的突变复发,因此即使考虑到网络信息也仍然未被发现。我们开发了一种称为mCGfinder的新方法,可以有效地检测具有患者间异质性的肿瘤样品中的突变癌症基因。基于结合了基因相互作用网络信息的矩阵分解框架,mCGfinder可以成功地测量样本子集中基因突变复发的重要性。当将mCGfinder用于五种类型癌症的TCGA体细胞突变数据集时,我们发现mCGfinder检测到的基因对于已知的癌症基因而言明显富集,并且比其他现有方法产生的p值要小得多。所有结果表明,mCGfinder是检测突变的癌症基因的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号